374 related articles for article (PubMed ID: 18552236)
1. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes.
Chen J; Hui ST; Couto FM; Mungrue IN; Davis DB; Attie AD; Lusis AJ; Davis RA; Shalev A
FASEB J; 2008 Oct; 22(10):3581-94. PubMed ID: 18552236
[TBL] [Abstract][Full Text] [Related]
2. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis.
Chen J; Saxena G; Mungrue IN; Lusis AJ; Shalev A
Diabetes; 2008 Apr; 57(4):938-44. PubMed ID: 18171713
[TBL] [Abstract][Full Text] [Related]
4. Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death.
Chen J; Fontes G; Saxena G; Poitout V; Shalev A
Diabetes; 2010 Feb; 59(2):440-7. PubMed ID: 19875615
[TBL] [Abstract][Full Text] [Related]
5. Lack of TXNIP protects beta-cells against glucotoxicity.
Shalev A
Biochem Soc Trans; 2008 Oct; 36(Pt 5):963-5. PubMed ID: 18793170
[TBL] [Abstract][Full Text] [Related]
6. Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein.
Chen J; Cha-Molstad H; Szabo A; Shalev A
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1133-9. PubMed ID: 19258488
[TBL] [Abstract][Full Text] [Related]
7. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.
Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW
Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980
[TBL] [Abstract][Full Text] [Related]
8. Preventing β-cell loss and diabetes with calcium channel blockers.
Xu G; Chen J; Jing G; Shalev A
Diabetes; 2012 Apr; 61(4):848-56. PubMed ID: 22442301
[TBL] [Abstract][Full Text] [Related]
9. Cytokines Regulate β-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways.
Hong K; Xu G; Grayson TB; Shalev A
J Biol Chem; 2016 Apr; 291(16):8428-39. PubMed ID: 26858253
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-interacting protein regulates insulin transcription through microRNA-204.
Xu G; Chen J; Jing G; Shalev A
Nat Med; 2013 Sep; 19(9):1141-6. PubMed ID: 23975026
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
12. SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice.
Qin K; Zhang N; Zhang Z; Nipper M; Zhu Z; Leighton J; Xu K; Musi N; Wang P
Diabetologia; 2018 Apr; 61(4):906-918. PubMed ID: 29322219
[TBL] [Abstract][Full Text] [Related]
13. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.
Myers RB; Fomovsky GM; Lee S; Tan M; Wang BF; Patwari P; Yoshioka J
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1748-59. PubMed ID: 27037370
[TBL] [Abstract][Full Text] [Related]
14. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression.
Zhang X; Zhao S; Yuan Q; Zhu L; Li F; Wang H; Kong D; Hao J
Cell Death Dis; 2021 Jun; 12(7):642. PubMed ID: 34162834
[TBL] [Abstract][Full Text] [Related]
15. Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets.
Shaked M; Ketzinel-Gilad M; Ariav Y; Cerasi E; Kaiser N; Leibowitz G
Diabetologia; 2009 Apr; 52(4):636-44. PubMed ID: 19214472
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis.
Minn AH; Hafele C; Shalev A
Endocrinology; 2005 May; 146(5):2397-405. PubMed ID: 15705778
[TBL] [Abstract][Full Text] [Related]
17. Endogenous hydrogen sulfide protects pancreatic beta-cells from a high-fat diet-induced glucotoxicity and prevents the development of type 2 diabetes.
Okamoto M; Yamaoka M; Takei M; Ando T; Taniguchi S; Ishii I; Tohya K; Ishizaki T; Niki I; Kimura T
Biochem Biophys Res Commun; 2013 Dec; 442(3-4):227-33. PubMed ID: 24246677
[TBL] [Abstract][Full Text] [Related]
18. Alpha Cell Thioredoxin-interacting Protein Deletion Improves Diabetes-associated Hyperglycemia and Hyperglucagonemia.
Lu B; Chen J; Xu G; Grayson TB; Jing G; Jo S; Shalev A
Endocrinology; 2022 Oct; 163(11):. PubMed ID: 35957590
[TBL] [Abstract][Full Text] [Related]
19. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein.
Saxena G; Chen J; Shalev A
J Biol Chem; 2010 Feb; 285(6):3997-4005. PubMed ID: 19959470
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone acetyltransferase by naringenin and hesperetin suppresses Txnip expression and protects pancreatic β cells in diabetic mice.
Wang SW; Sheng H; Bai YF; Weng YY; Fan XY; Zheng F; Fu JQ; Zhang F
Phytomedicine; 2021 Jul; 88():153454. PubMed ID: 33663922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
